Chronic pain is the number one health care problem worldwide and is estimated to affect one quarter of the world’s population. Women suffer significantly more from chronic pain than men, also experience more severe pain and are frequently less responsive to therapies that are effective in men. Chronic pain has both a sensory and an affective component in that chronic pain is often co-morbid with anxiety, depression and memory disorders. Finally, neuroinflammation is a significant contributor to the development of pain worldwide.

In recognition of such problem, Neuroinflammation & Gender (N&G) is initiated to investigate the biological basis of male/female differences in neuro-inflammation and chronic pain. N&G aims to secure an international leadership position for Drexel team in development and testing of targeted therapies and prevention strategies.

The team leading iDream includes:

• Prof. Bethea (Lead; CoAS)
• Prof. Bradt (CNHP)
• Prof. Cruciani (CoM)
• Prof. Friedman (CoE)
• Prof. Kaimal (CNHP)
• Prof. Mossy (Dornsife SPH)
• Prof. Moxon (Biomed)
• Prof. Nulton (CoAS)
• Prof. Noh (CoE)
• Prof. Spiller (Biomed)
• Prof. Weingarten (CoM)